Company profile
Eluceda
Eluceda is a detection technology business that delivers powerful detection solutions to brand protection, chemical and bacterial testing and other industrial processes.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
MR04 | Transaction MzQ0MTQyNTc0OGFkaXF6a2N4
Published 30 Oct 2024 10:23
SH01 | Transaction MzQzODczNzQxN2FkaXF6a2N4
Published 08 Oct 2024 01:20
SH01 | Transaction MzQzNzMzNTk1MWFkaXF6a2N4
Published 26 Sep 2024 08:50
PSC02 | Transaction MzQzNzM3OTg5OGFkaXF6a2N4
Published 26 Sep 2024 01:03
PSC09 | Transaction MzQzNzM3OTUxOGFkaXF6a2N4
Published 26 Sep 2024 01:01
SH01 | Transaction MzQzNzE5Njc3N2FkaXF6a2N4
Published 25 Sep 2024 12:37
SH01 | Transaction MzQzNzE5NTkxOGFkaXF6a2N4
Published 25 Sep 2024 12:31
MA | Transaction MzQzNjU0Mzk4NmFkaXF6a2N4 | Paper/PDF filed
Published 24 Sep 2024 06:28
RESOLUTIONS | Transaction QURCVDQyWkRhZGlxemtjeA | Paper/PDF filed
Published 24 Sep 2024 06:24
AP01 | Transaction MzQzNTk0MTA5N2FkaXF6a2N4
Published 16 Sep 2024 08:34
TM01 | Transaction MzQzNDYzNzAxOWFkaXF6a2N4
Published 05 Sep 2024 12:14
Company registered at Companies House
1 Dec 2022 to 31 May 2024
To support initiatives across the NHS to prevent healthcare-associated infections and the transmission of dangerous antimicrobial resistant pathogens, Eluceda Limited in collaboration with Infection Prevention and Control experts at the University of Manchester and Manchester University NHS Foundation Trust, aim to advance the development and validation o...
1 Oct 2020 to 30 Jun 2021
This project aims to develop a novel testing solution that allows the complete forensic fingerprinting of a range of aqueous consumer products (including pharmaceuticals and scotch whiskies) to reduce the number of counterfeit products that are able to be sold on the black market. This technology is based of novel state-of-the-art detection techniques dev...
1 Jan 2020 to 30 Jun 2021
**CHALLENGE:** Healthcare-associated infections (HCAIs) pose a serious threat to patients, staff and visitors, and significant cost to the NHS (£1billion/year). Infection prevention and control is therefore a key government/NHS priority and has generated significant public attention over the last decade.Appropriate disinfection of high-touch surfaces and ...
1 Jun 2015 to 30 Sep 2015
Eluceda Ltd will develop the next generation of biosensors; a platform able to operate in a wide variety of environments and making sensors truly democratic and ubiquitous. We will use our expertise in device development and optimisation to make these tests easy to use and accurate. These devices will be able to contribute to reducing product counterfeiti...
